12 Health Care Stocks Moving In Thursday’s Pre-Market Session
Gainers Tempest Therapeutics (NASDAQ:TPST) shares rose 32.8% to $3.79 during Thursday’s pre-market session. The company’s market cap stands…
12 Health Care Stocks Moving In Wednesday’s After-Market Session
Gainers Nexalin Technology (NASDAQ:NXL) stock increased by 48.1% to $1.54 during Wednesday’s after-market session. The company’s market cap…
12 Health Care Stocks Moving In Wednesday’s Intraday Session
Gainers Geovax Labs (NASDAQ:GOVX) stock moved upwards by 72.1% to $1.91 during Wednesday’s regular session. The company’s market…
12 Health Care Stocks Moving In Wednesday’s Pre-Market Session
Gainers Sonoma Pharmaceuticals (NASDAQ:SNOA) shares rose 60.2% to $0.27 during Wednesday’s pre-market session. The market value of their…
12 Health Care Stocks Moving In Friday’s Pre-Market Session
Gainers Venus Concept (NASDAQ:VERO) shares increased by 135.2% to $1.38 during Friday’s pre-market session. The market value of…
12 Health Care Stocks Moving In Thursday’s After-Market Session
Gainers OneMedNet (NASDAQ:ONMD) stock moved upwards by 15.6% to $1.7 during Thursday’s after-market session. The company’s market cap…
12 Health Care Stocks Moving In Wednesday’s After-Market Session
Gainers Sharps Technology (NASDAQ:STSS) stock increased by 56.5% to $0.4 during Wednesday’s after-market session. The market value of…
Elon Musk Breaks Ranks With GOP By Praising Genetic Engineering Tech That Helped Fight COVID-19: ‘Digital Medicine With Incredible Potential’
Elon Musk has come off as a flagbearer of the mRNA technology, which is seen holding out a lot of promise by scientists.
12 Health Care Stocks Moving In Friday’s Pre-Market Session
Gainers Protara Therapeutics (NASDAQ:TARA) stock increased by 40.3% to $5.64 during Friday’s pre-market session. The market value of…
GeoVax To Present Data On GEO-CM04S1, A Next Generation Covid-19 Vaccine, At The World Vaccine Congress
GeoVax Labs, Inc. (NASDAQ:GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today announced that its Chief Scientific Officer, Mark Newman, PhD, will present